The shortages, which have been going on for years, have typically affected only low-cost generics rather than profitable brand-name drugs.
The Medicines Patent Pool was created to promote public health, facilitating generic licensing for patented drugs that treat diseases predominantly affecting low- and middle-income countries.
Despite technological advancements, many challenges remain in getting a drug from lab to pharmacy shelf. Reframing what is a “medicine” could expand treatment options for researchers and patients.
Believe it or not, medication names are intended to be easy to remember and descriptive of the function they serve in the body.
From tablets and patches to ointments and infusions, the best way to deliver a drug is the one that gets the right amount to the right place.
About 1 in 4 Americans with diabetes who need insulin struggle to pay for this lifesaving drug.
An infections disease doctor discusses the use, benefits and availability of a drug to prevent severe COVID-19.
While technological advancements have quickened the drug discovery process, some chemical compounds remain a common thorn in a researcher’s side.
Drug repurposing can redeem failed treatments and squeeze out new uses from others. But many pharmaceutical companies are hesitant to retool existing drugs without a high return on investment.
Drug development is a long and costly process that often ends in failure. Improving the way potential drug candidates are optimized could help boost success rates.
/
2
